Prozkoumejte nejčtenější články a videa na Campus Sanofi
Traditional calcium-based binders can lead to hypercalcaemia and increase the risk of CV mortality in CKD patients.1 Renvela® (sevelamer carbonate) is a calcium-free and magnesium-free phosphate binder for the treatment of hyperphosphatemia in CKD patients, that does not increase the risk of hypercalcaemia.1-4